How Glucose and Fat Affect Aspirin Resistance in Diabetics
Author Information
Author(s): Yassine Hussein N., Davis-Gorman Grace, Stump Craig S., Thomson Stephen S., Peterson Justin, McDonagh Paul F.
Primary Institution: Arizona Health Sciences Center, University of Arizona
Hypothesis
The study aims to investigate the roles of acute hyperglycemia and hyperlipidemia on aspirin function in diabetic subjects with and without cardiovascular disease.
Conclusion
Saturated fat ingestion increases in vivo thromboxane production despite aspirin therapy.
Supporting Evidence
- Aspirin has lower antiplatelet activity in diabetic patients.
- Urine thromboxane increased significantly after fat ingestion.
- Diabetic subjects with cardiac disease showed increased thromboxane after glucose ingestion.
Takeaway
Eating a lot of fat can make aspirin less effective for people with diabetes, which is important to know for heart health.
Methodology
The study involved 55 diabetic subjects who underwent either a glucose or fat challenge while on aspirin therapy, measuring urine thromboxane and VerifyNow responses.
Potential Biases
The absence of a control group may introduce bias in interpreting the results.
Limitations
The study has a small sample size and lacks a control group.
Participant Demographics
Subjects were mostly Caucasian, middle-aged adults, with a majority being obese and having a history of hyperlipidemia and hypertension.
Statistical Information
P-Value
P < .05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website